U.S.-based Google DeepMind announced on November 11 (local time) an AI model, “AlphaGenome 2,” that predicts how DNA sequences and their mutations affect specific types of human cells. It aims to help elucidate cellular-level mechanisms that cause disease. For noncommercial research purposes, it is available through the “AlphaGenome API.” For commercial research, it will be offered as a limited preview. The first-generation “AlphaGenome,” announced last Ju